Home » Topics » Disease categories and therapies » Immune

Immune
RSS

New anti-TACI receptor antibodies and their use reported by Genentech

March 11, 2004

SBIR grant supports development of GelVac intranasal vaccine delivery platform

March 10, 2004

Altastaph receives fast track designation

March 8, 2004

German approval for Gamunex

March 8, 2004

Myfortic receives FDA approval

March 4, 2004

Menactra BLA accepted for filing

March 2, 2004

Pevion Biotech and AlgoNomics collaborate on rational vaccine development

March 2, 2004

New phase II/III trial for Dynavax ragweed allergy product

March 1, 2004

FDA agrees to dose range finding study for ISA-247

March 1, 2004

Effective prevention of viral ARI found with CVT-E002 in elderly subjects

Feb. 26, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...